Kim Donckers
Leuven, VLG, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
A coronavirus assembly inhibitor that targets the viral membrane protein.
Journal: Nature
Published: April 06, 2024
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors.
Journal: Science (New York, N.Y.)
Published: November 09, 2023
The Substitutions L50F, E166A, and L167F in SARS-CoV-2 3CLpro Are Selected by a Protease Inhibitor In Vitro and Confer Resistance To Nirmatrelvir.
Journal: mBio
Published: January 10, 2023
Nirmatrelvir-resistant SARS-CoV-2 is efficiently transmitted in female Syrian hamsters and retains partial susceptibility to treatment.
Journal: Nature communications
Published: November 07, 2022
A robust SARS-CoV-2 replication model in primary human epithelial cells at the air liquid interface to assess antiviral agents.
Journal: Antiviral research
Published: June 08, 2021
Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
Journal: Antimicrobial agents and chemotherapy
Published: April 03, 2020
Optimization of a Class of Tryptophan Dendrimers That Inhibit HIV Replication Leads to a Selective, Specific, and Low-Nanomolar Inhibitor of Clinical Isolates of Enterovirus A71.
Journal: Antimicrobial agents and chemotherapy
Published: March 21, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026